Log In

Forgot Password?
Create New Account

Loading... please wait

2023 Annual Meeting | C9 - Autoimmune Neurology: Paraneoplastic

Saturday 04/22/23
12:15 PM - 02:15 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Marianna Spatola, MD, PhD
Autoimmune Neurology
Participants will learn to recognize the clinical features of paraneoplastic neurologic disorders of the CNS, know the cancer association, the associated neuronal antibodies targeting intracellular antigens, and the techniques for their detection. This course will also illustrate how neuropathological findings can help diagnosis and will provide attendees with an overview of the experimental models of autoimmune paraneoplastic neurologic disorders and their therapeutic implications.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Neurohospitalist, Medical Student
Case-based, Didactic, Audience Participation
Event Timeline
12:15 PM - 12:50 PM EST Speaker Overview of Paraneoplastic Syndromes and Diagnostic Tips
Marianna Spatola, MD, PhD
12:50 PM - 01:25 PM EST Speaker Neuropathological Findings and Implications for Diagnosis
Romana Hoeftberger
01:25 PM - 02:00 PM EST Speaker Pathogenic Mechanisms: Immunological Bases of Paraneoplastic Syndromes and Therapeutic Implications
Roland Liblau
02:00 PM - 02:15 PM EST Discussion Questions and Answers
Marianna Spatola, MD, PhD, Romana Hoeftberger, Roland Liblau
Faculty Disclosures
Marianna Spatola, MD, PhD The institution of Dr. Spatola has received research support from Spanish National Health Institute (Carlos III). The institution of Dr. Spatola has received research support from Spanish National Institute of Health - Miguel Servet Grant.
Romana Hoeftberger Romana Hoeftberger has received personal compensation in the range of $500-$4,999 for serving as a speaker with Euroimmun, Biogen, Sanofi-Aventis, and UCB Biopharma.
Roland Liblau Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-genzyme. Roland Liblau has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Servier. Roland Liblau has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Opinion in Immunology. The institution of Roland Liblau has received research support from Roche. The institution of Roland Liblau has received research support from ARSEP. The institution of Roland Liblau has received research support from Fondation pour la Recherche Médicale. The institution of Roland Liblau has received research support from Population Bio UK, Inc. The institution of Roland Liblau has received research support from ANR.